All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection
We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the per...
Saved in:
Published in | Journal of hepatology Vol. 57; no. 4; pp. 743 - 751 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier B.V
01.10.2012
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 – 2008.
We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5year-age bands.
Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9–6.4), 2.4 (1.9–3.1) for HCV negative subjects and 11.5 (9.9–13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5–26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5–6.7). SMR for liver-related mortality was 1.8 (0.6–5.7) for HCV negative subjects vs. 22.4 (14.6–34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003.
There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes. |
---|---|
AbstractList | We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 – 2008.
We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5year-age bands.
Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9–6.4), 2.4 (1.9–3.1) for HCV negative subjects and 11.5 (9.9–13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5–26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5–6.7). SMR for liver-related mortality was 1.8 (0.6–5.7) for HCV negative subjects vs. 22.4 (14.6–34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003.
There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes. We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 - 2008. We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5 year-age bands. Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9-6.4), 2.4 (1.9-3.1) for HCV negative subjects and 11.5 (9.9-13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5-26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5-6.7). SMR for liver-related mortality was 1.8 (0.6-5.7) for HCV negative subjects vs. 22.4 (14.6-34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003. There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes. Background & Aims We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 – 2008. Methods We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5 year-age bands. Results Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9–6.4), 2.4 (1.9–3.1) for HCV negative subjects and 11.5 (9.9–13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5–26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5–6.7). SMR for liver-related mortality was 1.8 (0.6–5.7) for HCV negative subjects vs. 22.4 (14.6–34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003. Conclusions There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes. We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 - 2008.BACKGROUND & AIMSWe aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 - 2008.We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5 year-age bands.METHODSWe estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5 year-age bands.Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9-6.4), 2.4 (1.9-3.1) for HCV negative subjects and 11.5 (9.9-13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5-26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5-6.7). SMR for liver-related mortality was 1.8 (0.6-5.7) for HCV negative subjects vs. 22.4 (14.6-34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003.RESULTSOverall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9-6.4), 2.4 (1.9-3.1) for HCV negative subjects and 11.5 (9.9-13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5-26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5-6.7). SMR for liver-related mortality was 1.8 (0.6-5.7) for HCV negative subjects vs. 22.4 (14.6-34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003.There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes.CONCLUSIONSThere was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes. |
Author | Hernando, Victoria Dalmau, David Segura, Ferran Gonzalez, Juan Lewden, Charlotte Moreno, Santiago Perez-Cachafeiro, Santiago Oteo, Jose Antonio Rubio, Rafael Amo, Julia del |
Author_xml | – sequence: 1 givenname: Victoria surname: Hernando fullname: Hernando, Victoria email: vhernando@isciii.es organization: Red de Investigación en Sida, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain – sequence: 2 givenname: Santiago surname: Perez-Cachafeiro fullname: Perez-Cachafeiro, Santiago organization: Fundación IDI Complexo Hospitalario de Pontevedra, Pontevedra, Spain – sequence: 3 givenname: Charlotte surname: Lewden fullname: Lewden, Charlotte organization: INSERM, U897, Bordeaux, France – sequence: 4 givenname: Juan surname: Gonzalez fullname: Gonzalez, Juan organization: Hospital Universitario La Paz, Madrid, Spain – sequence: 5 givenname: Ferran surname: Segura fullname: Segura, Ferran organization: Corporació Sanitària Parc Tauli, Sabadell, Spain – sequence: 6 givenname: Jose Antonio surname: Oteo fullname: Oteo, Jose Antonio organization: Hospital San Pedro-CIBIR, Logroño, Spain – sequence: 7 givenname: Rafael surname: Rubio fullname: Rubio, Rafael organization: Hospital Universitario Doce de Octubre, Madrid, Spain – sequence: 8 givenname: David surname: Dalmau fullname: Dalmau, David organization: Hospital Universitarí Mutua de Terrassa, Terrassa, Spain – sequence: 9 givenname: Santiago surname: Moreno fullname: Moreno, Santiago organization: Hospital Universitário Ramón y Cajal, Madrid, Spain – sequence: 10 givenname: Julia del surname: Amo fullname: Amo, Julia del organization: Red de Investigación en Sida, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26340773$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22709620$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkk1v1DAURSNURKeFP8ACeYPEJsOz4zhJhZCq8jGVKrEAurUc55k6eJzUTirNll-Ow0yFVImy8uaca_len2RHfvCYZS8prClQ8bZf9zc4rhlQtgaxBgpPshUVADkITo-yVYLqvGZVfZydxNgDQAENf5YdM1ZBIxissl_nzuVazRGJ8h1x9g5DHtCpCTuyHcKknJ12xHqyubwm4xDtlBAS57ZHPUWih-2oQmKngUw3SH6gx6BcIsc5hdjBn5EP1hgM6DVG0u7I5uI6abn1JiUk4Hn21CgX8cXhPM2-f_r47WKTX335fHlxfpXrshBT3uii7jRAzUttoKJtazquGlFyNEIg413LdKNF1UFZtgVoZrRR2DE0pahqXZxmb_a5YxhuZ4yT3Nqo0TnlcZijpMAp5UVZ8oS-OqBzu8VOjsFuVdjJ-94S8PoAqKiVM0F5beNfThQcqqpIXL3ndBhiDGikttOfWqagrEt3ymVK2ctlSrlMKUHINGVS2QP1Pv1R6d1ewlTkncUgo7ZL850NqW3ZDfZx_f0DXTvrbXrhT9xh7Ic5-DSRpDImR35dPtjyvygD4IVoUsDZvwP-d_tvp0ng-w |
CODEN | JOHEEC |
CitedBy_id | crossref_primary_10_1093_cid_ciw846 crossref_primary_10_5501_wjv_v9_i5_54 crossref_primary_10_1111_dar_12425 crossref_primary_10_1097_QAD_0000000000002869 crossref_primary_10_1097_QAD_0000000000003312 crossref_primary_10_1016_S2352_3018_17_30030_9 crossref_primary_10_1097_QAD_0000000000002186 crossref_primary_10_3748_wjg_v25_i4_398 crossref_primary_10_1007_s10461_024_04436_6 crossref_primary_10_1080_19371918_2014_1000506 crossref_primary_10_4103_aam_aam_65_20 crossref_primary_10_1038_nrgastro_2014_17 crossref_primary_10_1371_journal_pone_0103345 crossref_primary_10_1186_s12879_021_06053_3 crossref_primary_10_1016_j_eimc_2015_07_016 crossref_primary_10_1186_s12879_016_1807_5 crossref_primary_10_1097_MD_0000000000010462 crossref_primary_10_1371_journal_pone_0118304 crossref_primary_10_1016_j_ijid_2018_01_021 crossref_primary_10_1097_QAD_0000000000000450 crossref_primary_10_2174_0118746136280350240214064332 crossref_primary_10_1371_journal_pone_0181004 crossref_primary_10_1371_journal_pone_0088623 crossref_primary_10_1093_infdis_jiaa279 crossref_primary_10_1097_QAD_0000000000000222 crossref_primary_10_1111_hiv_12937 crossref_primary_10_1089_apc_2015_0004 crossref_primary_10_1093_ofid_ofw105 crossref_primary_10_1016_j_eimc_2016_02_029 crossref_primary_10_1097_QAI_0000000000000603 crossref_primary_10_7759_cureus_15932 crossref_primary_10_1016_S0140_6736_13_60346_3 crossref_primary_10_1097_COH_0000000000000022 crossref_primary_10_17849_0743_6661_45_1_34 crossref_primary_10_1080_23744235_2021_1898046 crossref_primary_10_1002_cmdc_202000849 crossref_primary_10_1093_ofid_ofac672 crossref_primary_10_1007_s10096_015_2476_9 crossref_primary_10_2139_ssrn_4196958 crossref_primary_10_1111_jvh_12353 crossref_primary_10_1016_j_gtc_2015_07_003 crossref_primary_10_1097_COH_0000000000000306 crossref_primary_10_1111_jvh_12630 crossref_primary_10_1111_hiv_12125 crossref_primary_10_1016_j_dld_2016_06_004 crossref_primary_10_1093_cid_civ438 crossref_primary_10_1080_09540121_2015_1114994 crossref_primary_10_1186_s12876_020_01230_1 crossref_primary_10_1186_s12889_015_1565_0 crossref_primary_10_1007_s11904_015_0277_5 crossref_primary_10_1111_add_12367 crossref_primary_10_1016_j_psychres_2016_09_041 crossref_primary_10_1093_ofid_ofu104 crossref_primary_10_3390_v13102074 crossref_primary_10_1080_09540121_2020_1739209 crossref_primary_10_1093_cid_ciw120 crossref_primary_10_4236_health_2014_614212 crossref_primary_10_1016_j_aohep_2019_05_009 crossref_primary_10_1016_j_jana_2016_10_008 crossref_primary_10_1093_infdis_jis926 crossref_primary_10_1097_COH_0000000000000760 crossref_primary_10_2217_pgs_2018_0046 crossref_primary_10_1111_liv_13544 crossref_primary_10_1080_09540121_2021_1981221 crossref_primary_10_1093_cid_ciw379 crossref_primary_10_1186_s12955_021_01777_x crossref_primary_10_1186_s13722_015_0041_6 crossref_primary_10_1186_1471_2334_13_382 crossref_primary_10_1097_MD_0000000000016524 crossref_primary_10_1586_17474124_2014_876357 crossref_primary_10_1093_cid_ciu075 crossref_primary_10_1097_QAD_0000000000000377 crossref_primary_10_1007_s11904_014_0217_9 crossref_primary_10_1097_MD_0000000000002127 crossref_primary_10_1007_s11904_013_0182_8 crossref_primary_10_2196_45818 crossref_primary_10_1371_journal_pone_0116226 crossref_primary_10_1177_15248399231169793 crossref_primary_10_1016_S2468_1253_20_30303_4 crossref_primary_10_3748_wjg_v24_i5_613 crossref_primary_10_1089_apc_2015_0040 crossref_primary_10_12968_hmed_2017_78_9_516 crossref_primary_10_1097_QCO_0000000000000125 crossref_primary_10_1038_s41598_025_88530_2 crossref_primary_10_1097_MD_0000000000026507 crossref_primary_10_1016_j_eimce_2016_02_004 crossref_primary_10_1093_cid_cit326 crossref_primary_10_3851_IMP2960 crossref_primary_10_1097_COH_0000000000000183 crossref_primary_10_47102_annals_acadmedsg_V41N12p571 crossref_primary_10_1016_j_clinre_2015_04_001 crossref_primary_10_1016_j_med_2022_05_021 crossref_primary_10_1038_s41598_020_80311_3 crossref_primary_10_3390_cells10051212 crossref_primary_10_1097_MD_0000000000004727 crossref_primary_10_1097_QAD_0000000000002054 crossref_primary_10_1186_s12967_014_0341_8 |
Cites_doi | 10.1002/hep.23020 10.1016/j.jhep.2005.11.034 10.1086/520092 10.1157/13096749 10.1097/QAI.0b013e318134257a 10.1097/01.aids.0000163936.99401.fe 10.1097/01.qai.0000194232.85336.dc 10.3851/IMP1939 10.1016/S0140-6736(10)60932-4 10.1093/ije/dyp306 10.1086/652283 10.1093/ije/dyh307 10.1097/01.qai.0000233310.90484.16 10.1086/598333 10.1086/432762 10.1016/j.eimc.2011.06.002 10.1097/QAI.0b013e31817efb54 10.1111/j.1365-2559.2005.02243.x 10.1111/j.1440-1746.2008.05489.x 10.1097/QAI.0b013e3181acb4e5 10.1097/QAD.0b013e3283324283 10.1016/j.gaceta.2008.05.003 10.7326/0003-4819-138-3-200302040-00012 10.1111/j.1468-1293.2005.00271.x 10.1186/1471-2458-11-300 10.1097/01.aids.0000216375.99560.a2 10.1097/QAD.0b013e328352ada4 10.1097/QAD.0b013e32830e6d51 10.1111/j.1365-2893.2007.00903.x 10.1001/jama.300.1.51 10.1097/01.aids.0000192065.09281.01 10.1086/644771 10.1016/j.cld.2005.05.003 |
ContentType | Journal Article |
Copyright | 2012 European Association for the Study of the Liver European Association for the Study of the Liver 2015 INIST-CNRS Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2012 European Association for the Study of the Liver – notice: European Association for the Study of the Liver – notice: 2015 INIST-CNRS – notice: Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. |
CorporateAuthor | CoRIS |
CorporateAuthor_xml | – name: CoRIS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jhep.2012.06.010 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0641 |
EndPage | 751 |
ExternalDocumentID | 22709620 26340773 10_1016_j_jhep_2012_06_010 S0168827812004369 1_s2_0_S0168827812004369 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Spain |
GeographicLocations_xml | – name: Spain |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D-I DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W KOM LZ1 M27 M41 MJL MO0 N9A O-L O9- OAUVE OC. ON0 OVD OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UV1 WUQ X7M YOC Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c536t-9c38dc00845cf071bbfd4a9654ef66e24db2c9c67d055b30c2fcfaed2ef5678c3 |
IEDL.DBID | .~1 |
ISSN | 0168-8278 1600-0641 |
IngestDate | Thu Aug 07 15:22:50 EDT 2025 Mon Jul 21 05:51:08 EDT 2025 Mon Jul 21 09:14:41 EDT 2025 Tue Jul 01 02:21:27 EDT 2025 Thu Apr 24 23:05:41 EDT 2025 Fri Feb 23 02:27:18 EST 2024 Sun Feb 23 10:19:32 EST 2025 Tue Aug 26 20:13:18 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Standardized mortality ratio NSI MSM Mortality HIV VL AIDS ICD IQR cART Cause of death CoRIS-MD NBDF CoRIS HIV SMR HCV IDU p-y Human Immunodeficiency Virus Retrospective Cohort of Spanish Network on HIV/AIDS Research (in Spanish Cohorte de la Red de Investigación en SIDA) persons-year National Statistics Institute injecting drug user Acquired Immunodeficiency Syndrome Interquartile rate combined antiretroviral treatment Prospective Cohort of Spanish Network on HIV/AIDS Research (in Spanish Cohorte de la Red de Investigación en SIDA) Hepatitis C Virus International Classification of Diseases standardized mortality ratio men having sex with men National Basic Death File HIV viral load Human Immunopathology Mixed infection Prognosis Liver Retroviridae Hepatic disease Immune deficiency Lentivirus Epidemiology Infection Virus Viral disease Gastroenterology Digestive diseases Human immunodeficiency virus Viral hepatitis C |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c536t-9c38dc00845cf071bbfd4a9654ef66e24db2c9c67d055b30c2fcfaed2ef5678c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://hdl.handle.net/20.500.11940/7391 |
PMID | 22709620 |
PQID | 1041143554 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1041143554 pubmed_primary_22709620 pascalfrancis_primary_26340773 crossref_citationtrail_10_1016_j_jhep_2012_06_010 crossref_primary_10_1016_j_jhep_2012_06_010 elsevier_sciencedirect_doi_10_1016_j_jhep_2012_06_010 elsevier_clinicalkeyesjournals_1_s2_0_S0168827812004369 elsevier_clinicalkey_doi_10_1016_j_jhep_2012_06_010 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-10-01 |
PublicationDateYYYYMMDD | 2012-10-01 |
PublicationDate_xml | – month: 10 year: 2012 text: 2012-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: Netherlands |
PublicationTitle | Journal of hepatology |
PublicationTitleAlternate | J Hepatol |
PublicationYear | 2012 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Rockstroh, Mocroft, Soriano, Tural, Losso, Horban (b0085) 2005; 192 Backus, Boothroyd, Deyton (b0130) 2005; 19 Lewden, May, Rosenthal, Burty, Bonnet, Costagliola (b0135) 2008; 48 Sulkowski, Thomas (b0070) 2003; 138 Thein, Yi, Dore, Krahn (b0075) 2008; 22 Roulson, Benbow, Hasleton (b0210) 2005; 47 Aldaz, Moreno-Iribas, Egues, Irisarri, Floristan, Sola-Boneta (b0015) 2011; 11 Encuesta Nacional de Salud, año 2006. Instituto Nacional de Estadistica. Perez, del Amo, Iribarren, Salavert, Gutierrez, Moreno (b0100) 2009; 48 Berenguer J, Alejos-Ferreras B, Hernando V, Viciana P, Oteo JA, Gomez-Sirvent JL, et al. Temporal trends in liver-related mortality in a prospective cohort of HIV-infected patients in Spain, 1977–2008, 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome (Italy), July 2011 ed 2011. Hernando V, Sobrino-Vegas P, Burriel MC, Berenguer J, Navarro G, Santos I, et al. Differences in the causes of death of HIV positive subjects in a cohort study by data sources and coding algorithms. AIDS 2012, in press. [Epub ahead of print]. Salmon, Robain, Rockstroh, Benhamou (b0195) 2006; 44 Thomas, Seeff (b0205) 2005; 9 Gonzalez-Garcia, Mahillo, Hernandez, Pacheco, Diz, Garcia (b0105) 2005; 23 Krentz, Kliewer, Gill (b0005) 2005; 6 French, Gawel, Hershow, Benning, Hessol, Levine (b0025) 2009; 51 Sobrino-Vegas, Rodriguez-Urrego, Berenguer, Caro-Murillo, Blanco, Viciana (b0180) 2012; 17 Castellares, Barreiro, Martin-Carbonero, Labarga, Vispo, Casado (b0155) 2008; 15 Palella, Baker, Moorman, Chmiel, Wood, Brooks (b0010) 2006; 43 Lewden, Chene, Morlat, Raffi, Dupon, Dellamonica (b0030) 2007; 46 Zwahlen, Harris, May, Hogg, Costagliola, de Wolf (b0020) 2009; 38 Labarga, Soriano, Vispo, Pinilla, Martin-Carbonero, Castellares (b0200) 2007; 196 Lumbreras, Jarrin, del Amo, Perez-Hoyos, Muga, Garcia-de la Hera (b0095) 1990; 2006 Berenguer, Alvarez-Pellicer, Martin, Lopez-Aldeguer, Von Wichmann, Quereda (b0190) 2009; 50 Masia M, Perez-Cachafeiro S, Leyes M, López-Aldeguer J, López M, Segura F, et al., in press. Cardiovascular risk in HIV positive patients in Spain. CoRIS cohort, 2011. Enferm Infecc Microbiol Clin 2012 Bhaskaran, Hamouda, Sannes, Boufassa, Johnson, Lambert (b0040) 2008; 300 Sobrino-Vegas, Gutierrez, Berenguer, Labarga, Garcia, Alejos-Ferreras (b0125) 2011; 29 Ruppik M, Ledergerber B, Rickenbach M, Furrer H, Battegay M, Cavassini M, et al. Changing patterns of causes of death in the Swiss HIV Cohort Study (SHCS) 2005–2009. In: 18th conference on retroviruses and opportunistic infections; 2011. Konopnicki, Mocroft, de Wit, Antunes, Ledergerber, Katlama (b0055) 2005; 19 Pulido, Brugal, De la, Ballesta, Barrio, Bravo (b0150) 2009; 23 Rodriguez-Arenas MA, Gutierrez-Trujillo L, Robledano C, Rodríguez-Fortunez P, del Romero J, Rodriguez-Fernandez JM, et al. Prevalencia de consumo de drogas y adherencia a TARc, por sexo, en la cohorte hospitalario CoRIS de personas con infección por VIH., XIV Congreso Nacional sobre el SIDA, June. Zaragoza (Spain) ed 2011. Matthews, Dore (b0140) 2008; 23 Ray, Logan, Sterne, Hernadez-Diaz, Robins, Sabin (b0185) 2010; 24 Lodwick, Sabin, Porter, Ledergerber, van Sighem, Cozzi-Lepri (b0035) 2010; 376 . Smit, Geskus, Walker, Sabin, Coutinho, Porter (b0065) 2006; 20 The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010;50:1387–1396. Caro-Murillo, Castilla, Perez-Hoyos, Miro, Podzamczer, Rubio (b0120) 2007; 25 Ministry of Health SPaE. Patterns of mortality in Spain, 2008. 2011. Report No. Lewden, Salmon, Morlat, Bevilacqua, Jougla, Bonnet (b0060) 2005; 34 Sulkowski MS, Mehta SH, Montes de Oca R, Moore RD, Thomas DL. Estimated prevalence of significant liver disease among 4.052 HIV-infected adults with and without chronic viral hepatitis. In: 13th conference on retroviruses and opportunistic infections; 2006. Chen, Ding, Seage Iii, Kim (b0080) 2009; 49 del Amo, Perez-Hoyos, Moreno, Quintana, Ruiz, Cisneros (b0090) 2006; 41 French (10.1016/j.jhep.2012.06.010_b0025) 2009; 51 10.1016/j.jhep.2012.06.010_b0145 10.1016/j.jhep.2012.06.010_b0165 Lewden (10.1016/j.jhep.2012.06.010_b0030) 2007; 46 10.1016/j.jhep.2012.06.010_b0045 Perez (10.1016/j.jhep.2012.06.010_b0100) 2009; 48 Zwahlen (10.1016/j.jhep.2012.06.010_b0020) 2009; 38 10.1016/j.jhep.2012.06.010_b0160 Salmon (10.1016/j.jhep.2012.06.010_b0195) 2006; 44 Sulkowski (10.1016/j.jhep.2012.06.010_b0070) 2003; 138 Aldaz (10.1016/j.jhep.2012.06.010_b0015) 2011; 11 Castellares (10.1016/j.jhep.2012.06.010_b0155) 2008; 15 Bhaskaran (10.1016/j.jhep.2012.06.010_b0040) 2008; 300 Lewden (10.1016/j.jhep.2012.06.010_b0135) 2008; 48 Roulson (10.1016/j.jhep.2012.06.010_b0210) 2005; 47 Sobrino-Vegas (10.1016/j.jhep.2012.06.010_b0180) 2012; 17 Ray (10.1016/j.jhep.2012.06.010_b0185) 2010; 24 Lodwick (10.1016/j.jhep.2012.06.010_b0035) 2010; 376 Chen (10.1016/j.jhep.2012.06.010_b0080) 2009; 49 10.1016/j.jhep.2012.06.010_b0115 Thomas (10.1016/j.jhep.2012.06.010_b0205) 2005; 9 Lumbreras (10.1016/j.jhep.2012.06.010_b0095) 1990; 2006 Rockstroh (10.1016/j.jhep.2012.06.010_b0085) 2005; 192 Gonzalez-Garcia (10.1016/j.jhep.2012.06.010_b0105) 2005; 23 10.1016/j.jhep.2012.06.010_b0110 del Amo (10.1016/j.jhep.2012.06.010_b0090) 2006; 41 10.1016/j.jhep.2012.06.010_b0175 Konopnicki (10.1016/j.jhep.2012.06.010_b0055) 2005; 19 10.1016/j.jhep.2012.06.010_b0170 10.1016/j.jhep.2012.06.010_b0050 Matthews (10.1016/j.jhep.2012.06.010_b0140) 2008; 23 Palella (10.1016/j.jhep.2012.06.010_b0010) 2006; 43 Sobrino-Vegas (10.1016/j.jhep.2012.06.010_b0125) 2011; 29 Labarga (10.1016/j.jhep.2012.06.010_b0200) 2007; 196 Pulido (10.1016/j.jhep.2012.06.010_b0150) 2009; 23 Berenguer (10.1016/j.jhep.2012.06.010_b0190) 2009; 50 Thein (10.1016/j.jhep.2012.06.010_b0075) 2008; 22 Smit (10.1016/j.jhep.2012.06.010_b0065) 2006; 20 Caro-Murillo (10.1016/j.jhep.2012.06.010_b0120) 2007; 25 Backus (10.1016/j.jhep.2012.06.010_b0130) 2005; 19 Krentz (10.1016/j.jhep.2012.06.010_b0005) 2005; 6 Lewden (10.1016/j.jhep.2012.06.010_b0060) 2005; 34 |
References_xml | – volume: 15 start-page: 165 year: 2008 end-page: 172 ident: b0155 article-title: Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome publication-title: J Viral Hepat – reference: Masia M, Perez-Cachafeiro S, Leyes M, López-Aldeguer J, López M, Segura F, et al., in press. Cardiovascular risk in HIV positive patients in Spain. CoRIS cohort, 2011. Enferm Infecc Microbiol Clin 2012 – volume: 24 start-page: 123 year: 2010 end-page: 137 ident: b0185 article-title: The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals publication-title: AIDS – volume: 23 start-page: 1000 year: 2008 end-page: 1008 ident: b0140 article-title: HIV and hepatitis C coinfection publication-title: J Gastroenterol Hepatol – volume: 19 start-page: 593 year: 2005 end-page: 601 ident: b0055 article-title: Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort publication-title: AIDS – volume: 23 start-page: 200 year: 2009 end-page: 207 ident: b0150 article-title: Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the Itinere-cocaine Project) publication-title: Gac Sanit – volume: 25 start-page: 23 year: 2007 end-page: 31 ident: b0120 article-title: Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results publication-title: Enferm Infecc Microbiol Clin – volume: 376 start-page: 340 year: 2010 end-page: 345 ident: b0035 article-title: Death rates in HIV positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study publication-title: Lancet – volume: 49 start-page: 1605 year: 2009 end-page: 1615 ident: b0080 article-title: Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression publication-title: Clin Infect Dis – volume: 192 start-page: 992 year: 2005 end-page: 1002 ident: b0085 article-title: Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy publication-title: J Infect Dis – volume: 44 start-page: S2 year: 2006 end-page: S5 ident: b0195 article-title: Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference publication-title: J Hepatol – volume: 9 start-page: 383 year: 2005 end-page: 398 ident: b0205 article-title: Natural history of hepatitis C publication-title: Clin Liver Dis – volume: 23 start-page: 340 year: 2005 end-page: 348 ident: b0105 article-title: Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study publication-title: Enferm Infecc Microbiol Clin – reference: Hernando V, Sobrino-Vegas P, Burriel MC, Berenguer J, Navarro G, Santos I, et al. Differences in the causes of death of HIV positive subjects in a cohort study by data sources and coding algorithms. AIDS 2012, in press. [Epub ahead of print]. – volume: 19 start-page: S13 year: 2005 end-page: S19 ident: b0130 article-title: HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations publication-title: AIDS – volume: 48 start-page: 590 year: 2008 end-page: 598 ident: b0135 article-title: Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic) publication-title: J Acquir Immune Defic Syndr – volume: 17 start-page: 1 year: 2012 end-page: 8 ident: b0180 article-title: Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care publication-title: Antivir Ther – volume: 43 start-page: 27 year: 2006 end-page: 34 ident: b0010 article-title: Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study publication-title: J Acquir Immune Defic Syndr – reference: Ruppik M, Ledergerber B, Rickenbach M, Furrer H, Battegay M, Cavassini M, et al. Changing patterns of causes of death in the Swiss HIV Cohort Study (SHCS) 2005–2009. In: 18th conference on retroviruses and opportunistic infections; 2011. – volume: 41 start-page: 624 year: 2006 end-page: 631 ident: b0090 article-title: Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease publication-title: J Acquir Immune Defic Syndr – volume: 11 start-page: 300 year: 2011 ident: b0015 article-title: Mortality by causes in HIV-infected adults: comparison with the general population publication-title: BMC Pub Health – volume: 22 start-page: 1979 year: 2008 end-page: 1991 ident: b0075 article-title: Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis publication-title: AIDS – reference: Encuesta Nacional de Salud, año 2006. Instituto Nacional de Estadistica. – volume: 2006 start-page: 111 year: 1990 end-page: 116 ident: b0095 article-title: Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART publication-title: AIDS – volume: 47 start-page: 551 year: 2005 end-page: 559 ident: b0210 article-title: Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review publication-title: Histopathology – reference: Ministry of Health SPaE. Patterns of mortality in Spain, 2008. 2011. Report No.: – volume: 48 start-page: 1467 year: 2009 end-page: 1470 ident: b0100 article-title: Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997–2006 publication-title: Clin Infect Dis – volume: 20 start-page: 741 year: 2006 end-page: 749 ident: b0065 article-title: Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion publication-title: AIDS – reference: Berenguer J, Alejos-Ferreras B, Hernando V, Viciana P, Oteo JA, Gomez-Sirvent JL, et al. Temporal trends in liver-related mortality in a prospective cohort of HIV-infected patients in Spain, 1977–2008, 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome (Italy), July 2011 ed 2011. – volume: 46 start-page: 72 year: 2007 end-page: 77 ident: b0030 article-title: HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population publication-title: J Acquir Immune Defic Syndr – reference: . – volume: 6 start-page: 99 year: 2005 end-page: 106 ident: b0005 article-title: Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003 publication-title: HIV Med – volume: 300 start-page: 51 year: 2008 end-page: 59 ident: b0040 article-title: Changes in the risk of death after HIV seroconversion compared with mortality in the general population publication-title: JAMA – volume: 34 start-page: 121 year: 2005 end-page: 130 ident: b0060 article-title: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS publication-title: Int J Epidemiol – volume: 138 start-page: 197 year: 2003 end-page: 207 ident: b0070 article-title: Hepatitis C in the HIV-infected person publication-title: Ann Intern Med – volume: 38 start-page: 1624 year: 2009 end-page: 1633 ident: b0020 article-title: Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries publication-title: Int J Epidemiol – volume: 51 start-page: 399 year: 2009 end-page: 406 ident: b0025 article-title: Trends in mortality and causes of death among women with HIV in the United States: a 10-year study publication-title: J Acquir Immune Defic Syndr – volume: 196 start-page: 670 year: 2007 end-page: 676 ident: b0200 article-title: Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients publication-title: J Infect Dis – volume: 50 start-page: 407 year: 2009 end-page: 413 ident: b0190 article-title: Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus publication-title: Hepatology – reference: The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010;50:1387–1396. – volume: 29 start-page: 645 year: 2011 end-page: 653 ident: b0125 article-title: The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up publication-title: Enferm Infecc Microbiol Clin – reference: Sulkowski MS, Mehta SH, Montes de Oca R, Moore RD, Thomas DL. Estimated prevalence of significant liver disease among 4.052 HIV-infected adults with and without chronic viral hepatitis. In: 13th conference on retroviruses and opportunistic infections; 2006. – reference: Rodriguez-Arenas MA, Gutierrez-Trujillo L, Robledano C, Rodríguez-Fortunez P, del Romero J, Rodriguez-Fernandez JM, et al. Prevalencia de consumo de drogas y adherencia a TARc, por sexo, en la cohorte hospitalario CoRIS de personas con infección por VIH., XIV Congreso Nacional sobre el SIDA, June. Zaragoza (Spain) ed 2011. – volume: 23 start-page: 340 year: 2005 ident: 10.1016/j.jhep.2012.06.010_b0105 article-title: Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study publication-title: Enferm Infecc Microbiol Clin – volume: 50 start-page: 407 year: 2009 ident: 10.1016/j.jhep.2012.06.010_b0190 article-title: Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus publication-title: Hepatology doi: 10.1002/hep.23020 – volume: 44 start-page: S2 year: 2006 ident: 10.1016/j.jhep.2012.06.010_b0195 article-title: Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference publication-title: J Hepatol doi: 10.1016/j.jhep.2005.11.034 – volume: 196 start-page: 670 year: 2007 ident: 10.1016/j.jhep.2012.06.010_b0200 article-title: Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients publication-title: J Infect Dis doi: 10.1086/520092 – volume: 25 start-page: 23 year: 2007 ident: 10.1016/j.jhep.2012.06.010_b0120 article-title: Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results publication-title: Enferm Infecc Microbiol Clin doi: 10.1157/13096749 – volume: 46 start-page: 72 year: 2007 ident: 10.1016/j.jhep.2012.06.010_b0030 article-title: HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e318134257a – volume: 19 start-page: 593 year: 2005 ident: 10.1016/j.jhep.2012.06.010_b0055 article-title: Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort publication-title: AIDS doi: 10.1097/01.aids.0000163936.99401.fe – ident: 10.1016/j.jhep.2012.06.010_b0165 – volume: 41 start-page: 624 year: 2006 ident: 10.1016/j.jhep.2012.06.010_b0090 article-title: Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease publication-title: J Acquir Immune Defic Syndr doi: 10.1097/01.qai.0000194232.85336.dc – ident: 10.1016/j.jhep.2012.06.010_b0050 – volume: 2006 start-page: 111 year: 1990 ident: 10.1016/j.jhep.2012.06.010_b0095 article-title: Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART publication-title: AIDS – volume: 17 start-page: 1 year: 2012 ident: 10.1016/j.jhep.2012.06.010_b0180 article-title: Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care publication-title: Antivir Ther doi: 10.3851/IMP1939 – volume: 376 start-page: 340 year: 2010 ident: 10.1016/j.jhep.2012.06.010_b0035 article-title: Death rates in HIV positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study publication-title: Lancet doi: 10.1016/S0140-6736(10)60932-4 – volume: 38 start-page: 1624 year: 2009 ident: 10.1016/j.jhep.2012.06.010_b0020 article-title: Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries publication-title: Int J Epidemiol doi: 10.1093/ije/dyp306 – ident: 10.1016/j.jhep.2012.06.010_b0045 doi: 10.1086/652283 – volume: 34 start-page: 121 year: 2005 ident: 10.1016/j.jhep.2012.06.010_b0060 article-title: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS publication-title: Int J Epidemiol doi: 10.1093/ije/dyh307 – volume: 43 start-page: 27 year: 2006 ident: 10.1016/j.jhep.2012.06.010_b0010 article-title: Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study publication-title: J Acquir Immune Defic Syndr doi: 10.1097/01.qai.0000233310.90484.16 – volume: 48 start-page: 1467 year: 2009 ident: 10.1016/j.jhep.2012.06.010_b0100 article-title: Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997–2006 publication-title: Clin Infect Dis doi: 10.1086/598333 – volume: 192 start-page: 992 year: 2005 ident: 10.1016/j.jhep.2012.06.010_b0085 article-title: Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy publication-title: J Infect Dis doi: 10.1086/432762 – volume: 29 start-page: 645 year: 2011 ident: 10.1016/j.jhep.2012.06.010_b0125 article-title: The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up publication-title: Enferm Infecc Microbiol Clin doi: 10.1016/j.eimc.2011.06.002 – volume: 48 start-page: 590 year: 2008 ident: 10.1016/j.jhep.2012.06.010_b0135 article-title: Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic) publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31817efb54 – ident: 10.1016/j.jhep.2012.06.010_b0170 – volume: 47 start-page: 551 year: 2005 ident: 10.1016/j.jhep.2012.06.010_b0210 article-title: Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review publication-title: Histopathology doi: 10.1111/j.1365-2559.2005.02243.x – volume: 23 start-page: 1000 year: 2008 ident: 10.1016/j.jhep.2012.06.010_b0140 article-title: HIV and hepatitis C coinfection publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2008.05489.x – volume: 51 start-page: 399 year: 2009 ident: 10.1016/j.jhep.2012.06.010_b0025 article-title: Trends in mortality and causes of death among women with HIV in the United States: a 10-year study publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e3181acb4e5 – volume: 24 start-page: 123 year: 2010 ident: 10.1016/j.jhep.2012.06.010_b0185 article-title: The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals publication-title: AIDS doi: 10.1097/QAD.0b013e3283324283 – volume: 23 start-page: 200 year: 2009 ident: 10.1016/j.jhep.2012.06.010_b0150 article-title: Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the Itinere-cocaine Project) publication-title: Gac Sanit doi: 10.1016/j.gaceta.2008.05.003 – ident: 10.1016/j.jhep.2012.06.010_b0160 – volume: 138 start-page: 197 year: 2003 ident: 10.1016/j.jhep.2012.06.010_b0070 article-title: Hepatitis C in the HIV-infected person publication-title: Ann Intern Med doi: 10.7326/0003-4819-138-3-200302040-00012 – ident: 10.1016/j.jhep.2012.06.010_b0145 – volume: 6 start-page: 99 year: 2005 ident: 10.1016/j.jhep.2012.06.010_b0005 article-title: Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003 publication-title: HIV Med doi: 10.1111/j.1468-1293.2005.00271.x – volume: 11 start-page: 300 year: 2011 ident: 10.1016/j.jhep.2012.06.010_b0015 article-title: Mortality by causes in HIV-infected adults: comparison with the general population publication-title: BMC Pub Health doi: 10.1186/1471-2458-11-300 – volume: 20 start-page: 741 year: 2006 ident: 10.1016/j.jhep.2012.06.010_b0065 article-title: Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion publication-title: AIDS doi: 10.1097/01.aids.0000216375.99560.a2 – ident: 10.1016/j.jhep.2012.06.010_b0110 – ident: 10.1016/j.jhep.2012.06.010_b0115 doi: 10.1097/QAD.0b013e328352ada4 – ident: 10.1016/j.jhep.2012.06.010_b0175 – volume: 22 start-page: 1979 year: 2008 ident: 10.1016/j.jhep.2012.06.010_b0075 article-title: Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis publication-title: AIDS doi: 10.1097/QAD.0b013e32830e6d51 – volume: 15 start-page: 165 year: 2008 ident: 10.1016/j.jhep.2012.06.010_b0155 article-title: Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome publication-title: J Viral Hepat doi: 10.1111/j.1365-2893.2007.00903.x – volume: 300 start-page: 51 year: 2008 ident: 10.1016/j.jhep.2012.06.010_b0040 article-title: Changes in the risk of death after HIV seroconversion compared with mortality in the general population publication-title: JAMA doi: 10.1001/jama.300.1.51 – volume: 19 start-page: S13 year: 2005 ident: 10.1016/j.jhep.2012.06.010_b0130 article-title: HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations publication-title: AIDS doi: 10.1097/01.aids.0000192065.09281.01 – volume: 49 start-page: 1605 year: 2009 ident: 10.1016/j.jhep.2012.06.010_b0080 article-title: Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression publication-title: Clin Infect Dis doi: 10.1086/644771 – volume: 9 start-page: 383 year: 2005 ident: 10.1016/j.jhep.2012.06.010_b0205 article-title: Natural history of hepatitis C publication-title: Clin Liver Dis doi: 10.1016/j.cld.2005.05.003 |
SSID | ssj0003094 |
Score | 2.3916423 |
Snippet | We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS... Background & Aims We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 743 |
SubjectTerms | Acquired Immunodeficiency Syndrome - mortality Adult Biological and medical sciences Cause of death Coinfection - mortality Female Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen HCV Hepatitis C, Chronic - mortality Heterosexuality - statistics & numerical data HIV HIV Seropositivity - mortality Homosexuality, Male - statistics & numerical data Human viral diseases Humans Infectious diseases Liver Diseases - mortality Liver Diseases - virology Male Medical sciences Mortality Spain - epidemiology Standardized mortality ratio Substance Abuse, Intravenous - mortality Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral hepatitis |
Title | All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0168827812004369 https://www.clinicalkey.es/playcontent/1-s2.0-S0168827812004369 https://dx.doi.org/10.1016/j.jhep.2012.06.010 https://www.ncbi.nlm.nih.gov/pubmed/22709620 https://www.proquest.com/docview/1041143554 |
Volume | 57 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEF9KBRFE_DZVjxV8k-1lP5P4dpyWVG0RtaVvy2azW6-cuaO5E3zxwb_c2WRzpVgr-BQSdpLN7mTmt5vfzCD00nJb5JQ6YpXxRBTUE-O5IR4sH7O2qGoVgpMPDlV5JN6dyJMtNB1iYQKtMtr-3qZ31jpeGcfRHC9ns_FnACsADzPwUF0e9RDEJ0QWtHz35wXNg6dFzO-dk9A6Bs70HK-zry7krAz7gWo3DVG0Vzun20vTwpD5vtbF38Fo55T27qI7EU3iSd_he2jLNffRzYP4v_wB-jWZz4k169Zh09R4HkgYpAtfcTX-1iFvQOF41uBy_xj3BK7vDrfrKmzPtHhgqOPVAgNSxKd9kmpoOZT9eo3fxBIrYHBw9QOX02MQIwPJq3mIjvbefpmWJFZdIFZytSKF5XltQ559aT0AkKrytTCFksJ5pRwTdcVsYVVWp1JWPLXMW29czZyX4Pksf4S2m0XjniDsJUs9yxyzcAsOSzXKjHHeuZxaYUWeIDoMt7YxJXmojDHXA_fsTIcp0mGKdCDg0TRBrzYyyz4hx7Wt-TCLegg1BeOowV9cK5VdJeXa-H23muoWGus_dDBBciN5SY3_-cTRJRXbvBpTHJbcGU_Qi0HnNBiA8FfHNG6xhq6kggbQK0WCHvfKeCHNMliisnTnP7v1FN0KZz158RnaXp2v3XMAYatq1H1lI3RjMv304WM47r8vD38DyZ8zxw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-NTgKkCfE1CB_DSLwh08SO88FbVZhStvaFbdqb5Tg2dCpptbRIvPKXc06cookxJF4TX-LYl7uf7d_dAbzRXOdZFBmqE2VpnEeWKssVtWj5mNZ5WSUuOHk6S4rT-NO5ON-BcR8L42iV3vZ3Nr211v7K0I_mcDWfDz8jWEF4mKKHavOo57dg12WnEgPYHU2OitnWIPMw9ym-M-oEfOxMR_O6-Gpc2kq3JZi8C10g7fX-aW-lGhw125W7-Dsebf3S4X245wElGXV9fgA7pn4It6f-yPwR_BwtFlSrTWOIqiuycDwM2kawmIp8a8E3AnEyr0kxOSMdh-u7Ic2mdDs0DelJ6mS9JAgWyZcuTzW27Ct_vScffJUVtDmk_EGK8RmK0Z7nVT-G08OPJ-OC-sILVAuerGmueVZpl2pfaIsYpCxtFas8EbGxSWJYXJVM5zpJq1CIkoeaWW2VqZixAp2f5vswqJe1eQrEChZalhqm8REcV2sRU8pYY7JIxzrOAoj64ZbaZyV3xTEWsqefXUg3RdJNkXQcvCgM4O1WZtXl5LixNe9nUfbRpmgfJbqMG6XS66RM43_xRkaywcbyDzUMQGwlr2jyP994cEXFtp_GEo6r7pQH8LrXOYk2wB3sqNosN9iVMI4c7hVxAE86ZfwtzVJcpbLw2X926xXcKU6mx_J4Mjt6DnfdnY7L-AIG68uNeYmYbF0e-H_uF5RLNOM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=All-cause+and+liver-related+mortality+in+HIV+positive+subjects+compared+to+the+general+population%3A+differences+by+HCV+co-infection&rft.jtitle=Journal+of+hepatology&rft.au=Hernando%2C+Victoria&rft.au=Perez-Cachafeiro%2C+Santiago&rft.au=Lewden%2C+Charlotte&rft.au=Gonzalez%2C+Juan&rft.date=2012-10-01&rft.eissn=1600-0641&rft.volume=57&rft.issue=4&rft.spage=743&rft_id=info:doi/10.1016%2Fj.jhep.2012.06.010&rft_id=info%3Apmid%2F22709620&rft.externalDocID=22709620 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01688278%2FS0168827812X00102%2Fcov150h.gif |